Role of Human Cds1 (Chk2) Kinase in DNA Damage Checkpoint and Its Regulation by p53
Kaoru Tominaga(Jichi Medical University), Makoto Nakanishi(The Cancer Institute Hospital), Kyoji Ikeda(National Center for Geriatrics and Gerontology), Hiroto Okayama(The University of Tokyo), Momoki Hirai(Tokyo University of Science), Motoaki Ohtsubo(Memorial Sloan Kettering Cancer Center), Takashi Tanaka(Nagoya City University), Atsushi Fujimoto(National Center for Geriatrics and Gerontology), Yoko Kaneko(Keio University), Hirobumi Morisaki(National Center for Geriatrics and Gerontology)
Cited by 100
Related Papers
Navigating the DNA methylation landscape of cancer
|Trends in Genetics|2021|1k
Aberrant cell cycle checkpoint function and early embryonic death in <i>Chk1</i><sup>−/−</sup> mice
|Genes & Development|2000|469
Chk2‐deficient mice exhibit radioresistance and defective p53‐mediated transcription
|The EMBO Journal|2002|436